Table 1.

Eligibility criteria

	Round 1 (n = 30)	Round 2 (n = 15)
Inclusion criteria	• Aged ≥12 years at time of consent • EITHER:  ◦ Severe AA diagnosed by a clinician and determined by SALT ≥50% and never treated with JAKi, or  ◦ Has received successful JAKi treatment, with SALT ≥50 prior to treatment	• Aged 18–60 years at time of consent • Severe AA diagnosed by a clinician and determined by SALT ≥50% • Current AA episode lasting > 6 months and no scalp hair regrowth over the past 6 months
	• A history of AA episodes lasting > 6 months but < 8 years • Sufficient physical, cognitive, reading and linguistic capacities to allow patients to actively participate in a 90 − minute interview • Fluent in English and can give documented informed consent
Exclusion criteria	• Diagnosed with androgenic alopecia	• Diagnosed with other forms of alopecia including male or female pattern hair loss • Has experienced ≥95% scalp hair loss for ≥8 years
	• Diagnosed with active psoriasis, atopic dermatitis, or other dermatological condition that could be severe enough to impact this study, or any other serious condition that could interfere with this study • Known substance abusers

Abbreviations: AA Alopecia areata, JAKi Janus kinase inhibitors, SALT Severity of Alopecia Tool